![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 3 of 3. This is the beginning of the thread.
Posted by jrbecker76 on March 1, 2008, at 14:48:39
Pristiq (Desvenlafaxine succinate), a metabolite of Effexor (venlafaxine), was approved yesterday by the FDA.
http://www.reuters.com/article/healthNews/idUSN2923853420080229
Posted by Phillipa on March 1, 2008, at 15:28:03
In reply to Pristiq (desvenlafaxine) approved by FDA, posted by jrbecker76 on March 1, 2008, at 14:48:39
Even the article mentions it may not have any advantages over the shall we say olders forms of effexor but the way it is broken down in the body. So what does this mean? Phillipa
Posted by yxibow on March 1, 2008, at 16:05:00
In reply to Re: Pristiq (desvenlafaxine) approved by FDA » jrbecker76, posted by Phillipa on March 1, 2008, at 15:28:03
> Even the article mentions it may not have any advantages over the shall we say olders forms of effexor but the way it is broken down in the body. So what does this mean? Phillipa
A patent extension basically. It would be nice if some companies could more fastrack their novel agents, but it is so hard to get new psychiatric compounds on the market. Other types of agents for other illnesses are being developed much quicker. In a way as my doctor said, we are in the middle ages of psychiatry -- not to be depressing, but we don't know how everything works.
A few things aren't completely patent extensions, like Lexapro is cleaner, and Wellbutrin SR/XL can help with seizure thresholds much better.
Only time will say whether this one also helps some people with metabolizing.
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.